Your search returned 2 results.

Results
	1.	Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors. [electronic resource] by Nagaoka, Tadahiro Karasawa, Hideaki Turbyville, Thomas Rangel, Maria-Cristina Castro, Nadia P Gonzales, Monica Baker, Alyson Seno, Masaharu Lockett, Stephen Greer, Yoshimi E Rubin, Jeffrey S Salomon, David S Bianco, Caterina Producer: 20130430 In: Cellular signalling vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. [electronic resource] by Dine, Jennifer L O'Sullivan, Ciara C Voeller, Donna Greer, Yoshimi E Chavez, Kathryn J Conway, Catherine M Sinclair, Sarah Stone, Brandon Amiri-Kordestani, Laleh Merchant, Anand S Hewitt, Stephen M Steinberg, Seth M Swain, Sandra M Lipkowitz, Stanley Producer: 20161014 In: Breast cancer research and treatment vol. 155 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search